<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>34</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Correlation of PSA Levels with Inflammatory and Hematological Biomarkers for Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia</title>
	<subject_fa>Clinical Medicine</subject_fa>
	<subject>Clinical Medicine</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Background &amp; Objective:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;span lang=&quot;EN&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Differentiating prostate cancer (PC) from benign prostatic hyperplasia (BPH) remains clinically challenging due to overlapping symptoms and biomarker alterations. This study compared biochemical, hematological, and inflammatory markers between the two conditions to assess their potential diagnostic value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;b&gt;&lt;span lang=&quot;EN-IN&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Materials &amp; Methods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &amp;nbsp;&lt;span lang=&quot;EN&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;A cross-sectional study was performed on 40 patients with PC and 120 patients with benign prostatic hyperplasia. The measurement of biochemical parameters included complete blood count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and total and free prostate-specific antigen (PSA). The process involved statistical comparisons, ROC analysis, and correlation tests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-IN&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;span lang=&quot;EN&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Compared to BPH, patients with PC had significantly higher PSA (free and total), CRP, and lymphocyte counts (all p &lt; 0.05). Despite the diagnostic utility of PSA and inflammatory markers (AUCs 0.68&amp;ndash;0.80), hematological parameters in isolation were not strong discriminators (AUCs &lt; 0.50), and a combined biomarker strategy would be more effective in clinical discrimination.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;span lang=&quot;EN&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Detection of PC from BPH can be more accurately achieved by assessing elevated free and total PSA levels, along with increased systemic inflammation, as indicated by CRP. The independent discriminant value of hematologic parameters is limited despite significant differences between groups. A combination of PSA and inflammatory markers in a two-biomarker strategy can improve clinical discrimination and reduce inappropriate therapy.&lt;/span&gt;&lt;/span&gt;&lt;b&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>PSA, BPH, prostate cancer, CRP, ESR, NLR, PLR</keyword>
	<start_page>146</start_page>
	<end_page>155</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-5630-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hayder Ahmed</first_name>
	<middle_name></middle_name>
	<last_name>Sahar Algburi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hayder1261998@gmail.com</email>
	<code>5200319475328460090076</code>
	<orcid>5200319475328460090076</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmad </first_name>
	<middle_name></middle_name>
	<last_name>Deylami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090077</code>
	<orcid>0009-0000-2523-4653</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hadis</first_name>
	<middle_name></middle_name>
	<last_name>Musavi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090078</code>
	<orcid>0009-0000-2523-4653</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein </first_name>
	<middle_name></middle_name>
	<last_name>Mokhtari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090079</code>
	<orcid>5200319475328460090079</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Amol Faculty of Paramedicine, Mazandaran University of Medical Sciences, Sari, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neda</first_name>
	<middle_name></middle_name>
	<last_name>Masoumi Qajari </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090080</code>
	<orcid>0009-0004-8523-0856</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Genetic biology, Tonekabon Islamic Azad University, Tonekabon, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Lotfi Asrami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090081</code>
	<orcid>0009-0004-5185-3318</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biochemistry, Biophysics, Genetics and Nutrition, School of Medicine, Golestan University of Medical Sciences, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abbas </first_name>
	<middle_name></middle_name>
	<last_name>Khonakdar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460090082</code>
	<orcid>5200319475328460090082</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
